Dihexa | Cognitive Research Peptide
AUD $200
For laboratory research use only. Not for human use.
Research-grade Dihexa — a nootropic peptide derived from angiotensin IV, studied in preclinical models for cognitive enhancement, neurogenesis, and neuroprotection. Third-party HPLC tested to ≥98% purity. For laboratory research use only.
Supply Specifications
| Peptide | Dihexa (N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) |
| Format | Lyophilised powder |
| Purity | ≥98% by HPLC |
| Testing | Third-party HPLC + Mass Spec |
| Storage | -20°C lyophilised |
| Use | Laboratory research use only |
| Price | AUD $200 |
Research Summary
Dihexa is a nootropic peptide derived from angiotensin IV, developed at Washington State University. Preclinical studies in rodent models have observed apparent cognitive enhancement effects, with researchers noting apparent improvements in spatial memory and learning tasks.
Research has examined Dihexa's apparent role in promoting synaptogenesis and neurogenesis through hepatocyte growth factor (HGF) and its receptor c-Met. It is not TGA-approved for human use in Australia and is available for laboratory research use only.
Related Research
Disclaimer: All products supplied by PeptideIQ are for laboratory research use only. They are not approved for human use, consumption, or therapeutic application. PeptideIQ complies with all applicable Australian regulations including the Therapeutic Goods Act 1989.